338 related articles for article (PubMed ID: 16925794)
41. Comparison of the clinical usefulness of two quantitative D-Dimer tests in patients with a low clinical probability of pulmonary embolism.
Djurabi RK; Klok FA; Nijkeuter M; Kaasjager K; Kamphuisen PW; Kramer MH; Kruip MJ; Leebeek FW; Büller HR; Huisman MV
Thromb Res; 2009 Mar; 123(5):771-4. PubMed ID: 18814904
[TBL] [Abstract][Full Text] [Related]
42. Comparison of D-dimer point of care test (POCT) against current laboratory test in patients with suspected venous thromboembolism (VTE) presenting to the emergency department (ED).
Sen B; Kesteven P; Avery P
J Clin Pathol; 2014 May; 67(5):437-40. PubMed ID: 24307452
[TBL] [Abstract][Full Text] [Related]
43. Diagnostic accuracy of the Triage D-dimer test for exclusion of venous thromboembolism in outpatients.
Ghys T; Achtergael W; Verschraegen I; Leus B; Jochmans K
Thromb Res; 2008; 121(6):735-41. PubMed ID: 17888501
[TBL] [Abstract][Full Text] [Related]
44. Managing suspected venous thromboembolism in a mixed primary and secondary care setting using standard clinical assessment and D-dimer in a noninvasive diagnostic strategy.
de Bastos MM; Bastos MR; Pessoa PC; Bogutchi T; Carneiro-Proietti AB; Rezende SM
Blood Coagul Fibrinolysis; 2008 Jan; 19(1):48-54. PubMed ID: 18180615
[TBL] [Abstract][Full Text] [Related]
45. Validation of a new D-dimer microparticle enzyme immunoassay (AxSYM D-Dimer) in patients with suspected pulmonary embolism (PE).
Ghanima W; Sandset PM
Thromb Res; 2007; 120(4):471-6. PubMed ID: 17161451
[TBL] [Abstract][Full Text] [Related]
46. High plasma D-dimer level is associated with decreased survival in patients with lung cancer.
Altiay G; Ciftci A; Demir M; Kocak Z; Sut N; Tabakoglu E; Hatipoglu ON; Caglar T
Clin Oncol (R Coll Radiol); 2007 Sep; 19(7):494-8. PubMed ID: 17513096
[TBL] [Abstract][Full Text] [Related]
47. Clinical outcomes and factors predicting development of venous thromboembolic complications in patients with advanced refractory cancer in a Phase I Clinic: the M. D. Anderson Cancer Center experience.
Vemulapalli S; Chintala L; Tsimberidou AM; Dhillon N; Lei X; Hong D; Kurzrock R
Am J Hematol; 2009 Jul; 84(7):408-13. PubMed ID: 19437507
[TBL] [Abstract][Full Text] [Related]
48. D-dimer is not a long-term prognostic marker following acute cerebral ischemia.
Squizzato A; Ageno W; Finazzi S; Mera V; Romualdi E; Bossi A; Venco A
Blood Coagul Fibrinolysis; 2006 Jun; 17(4):303-6. PubMed ID: 16651873
[TBL] [Abstract][Full Text] [Related]
49. Impact of D-Dimer for Prediction of Incident Occult Cancer in Patients with Unprovoked Venous Thromboembolism.
Han D; ó Hartaigh B; Lee JH; Cho IJ; Shim CY; Chang HJ; Hong GR; Ha JW; Chung N
PLoS One; 2016; 11(4):e0153514. PubMed ID: 27073982
[TBL] [Abstract][Full Text] [Related]
50. Optimal dosing of bemiparin as prophylaxis against venous thromboembolism in surgery for cancer: an audit of practice.
Balibrea JL; Altimiras J; Larruzea I; Gómez-Outes A; Martínez-González J; Rocha E;
Int J Surg; 2007 Apr; 5(2):114-9. PubMed ID: 17448976
[TBL] [Abstract][Full Text] [Related]
51. D-dimer levels correlate with mortality in patients with acute pulmonary embolism: Findings from the RIETE registry.
Grau E; Tenías JM; Soto MJ; Gutierrez MR; Lecumberri R; Pérez JL; Tiberio G;
Crit Care Med; 2007 Aug; 35(8):1937-41. PubMed ID: 17581488
[TBL] [Abstract][Full Text] [Related]
52. Reduced efficacy of clinical probability score and D-dimer assay in elderly subjects suspected of having deep vein thrombosis.
Schutgens RE; Haas FJ; Biesma DH
Br J Haematol; 2005 Jun; 129(5):653-7. PubMed ID: 15916688
[TBL] [Abstract][Full Text] [Related]
53. Venous thromboembolism in trauma: a local manifestation of systemic hypercoagulability?
Meissner MH; Chandler WL; Elliott JS
J Trauma; 2003 Feb; 54(2):224-31. PubMed ID: 12579044
[TBL] [Abstract][Full Text] [Related]
54. Novel high-sensitive D-dimer determination predicts chemotherapy-associated venous thromboembolism in intermediate risk lung cancer patients.
Ferroni P; Martini F; Portarena I; Massimiani G; Riondino S; La Farina F; Mariotti S; Guadagni F; Roselli M
Clin Lung Cancer; 2012 Nov; 13(6):482-7. PubMed ID: 22591606
[TBL] [Abstract][Full Text] [Related]
55. Clinical conditions and patient factors significantly influence diagnostic utility of D-dimer in venous thromboembolism.
Qasim A; Duggan M; O'Connell N; O'Driscoll A
Blood Coagul Fibrinolysis; 2009 Jun; 20(4):244-7. PubMed ID: 19276796
[TBL] [Abstract][Full Text] [Related]
56. Screening strategy using sequential serum D-dimer assay for the detection and prevention of venous thromboembolism after elective brain tumor surgery.
Aishima K; Yoshimoto Y
Br J Neurosurg; 2013 Jun; 27(3):348-54. PubMed ID: 23131147
[TBL] [Abstract][Full Text] [Related]
57. Risk of venous thromboembolism in patients with borderline quantitative D-dimer levels.
Taira T; Taira BR; Carmen M; Chohan J; Singer AJ
Am J Emerg Med; 2010 May; 28(4):450-3. PubMed ID: 20466224
[TBL] [Abstract][Full Text] [Related]
58. D-dimer in patients with suspected acute mesenteric ischemia.
Chiu YH; Huang MK; How CK; Hsu TF; Chen JD; Chern CH; Yen DH; Huang CI
Am J Emerg Med; 2009 Oct; 27(8):975-9. PubMed ID: 19857417
[TBL] [Abstract][Full Text] [Related]
59. D-dimer at venous thrombosis diagnosis is associated with risk of recurrence.
Bjøri E; Johnsen HS; Hansen JB; Braekkan SK
J Thromb Haemost; 2017 May; 15(5):917-924. PubMed ID: 28166605
[TBL] [Abstract][Full Text] [Related]
60. D-dimer levels and risk of recurrent venous thromboembolism.
Eichinger S; Minar E; Bialonczyk C; Hirschl M; Quehenberger P; Schneider B; Weltermann A; Wagner O; Kyrle PA
JAMA; 2003 Aug; 290(8):1071-4. PubMed ID: 12941680
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
